Testing new coronavirus vaccines in early clinical trials
Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-11042071
This study is testing new coronavirus vaccines to see how safe and effective they are, and it's looking for people to join who want to help find better ways to protect against COVID-19.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-11042071 on ClinicalTrials.gov |
What this research studies
This research focuses on conducting early-phase clinical trials to evaluate next-generation coronavirus vaccines. Patients will be involved in trials that assess the safety and effectiveness of these new vaccine candidates. The trials will follow standardized protocols to ensure reliable data is collected, which will help determine which vaccines should be advanced for further development. Participants may receive either the vaccine candidate or a placebo as part of the trial process.
Who could benefit from this research
Good fit: Ideal candidates for participation include adults who are at risk of coronavirus infection or those who are interested in contributing to vaccine development.
Not a fit: Patients who are not at risk for coronavirus or those who have already received a vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against coronavirus, improving public health outcomes.
How similar studies have performed: Previous clinical trials for coronavirus vaccines have shown success, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DATTA, KIRAN — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: DATTA, KIRAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: National Institute of Allergy and Infectious Disease